Vivus (VVUS) Defends Qsymia IP from Another Generic Giant, RBC Capital Comments
Tweet Send to a Friend
RBC Capital analyst Simos Simeonidis reiterated an Outperform rating and $6 price target on Vivus (NASDAQ: VVUS) after the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
